Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer

Patent · Thu Jan 01 00:00:00 EST 1998

OSTI ID:871808

Gray, Joe W ^[1]; Collins, Colin ^[2]; Pinkel, Daniel ^[3]; Kallioniemi, Olli-Pekka ^[4]; Tanner, Minna M ^[4]

---

1. San Francisco, CA
2. San Rafael, CA
3. Walnut Creek, CA
4. Tampere, FI

The present invention relates to in situ hybridization methods for the identification of new chromosomal abnormalities associated with various diseases. In particular, it provides probes which are specific to a region of amplification in chromosome 20.

• Research Organization: Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
• DOE Contract Number: W-7405-ENG-48
• Assignee: Regents of University of California (Oakland, CA)
• Patent Number(s): US 5801021
• OSTI ID: 871808
• Country of Publication: United States
• Language: English

Related Subjects

amplifications
chromosomal
region
20q13
prognostic
indicator
breast
cancer
relates
situ
hybridization
methods
identification
abnormalities
associated
various
diseases
particular
provides
probes
specific
amplification
chromosome
20
various diseases
chromosomal abnormalities
hybridization methods
breast cancer
situ hybridization
provides probes
abnormalities associated
chromosomal region
prognostic indicator
/435/999/